Citius Oncology Inc. (CTOR) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Citius Oncology Inc.

    NASDAQ: CTOR · Real-Time Price · USD
    1.91
    0.02 (1.06%)
    At close: Oct 03, 2025, 3:59 PM

    Citius Oncology Income Statement

    Financials in USD. Fiscal year is October - September.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2021
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Apr 30, 2021
    Revenue
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Operating Income
    		 -4.94M -7.47M -6.39M -6.67M -383.96K -268.43K -4.58M -421.45K -199.55K -147.92K -138.12K -7.42M -2.3M n/a
    Interest Income
    		 n/a n/a n/a n/a 636.42K 758.26K 1.28M 579.4K 815.85K 759.65K 493.02K n/a n/a n/a
    Pretax Income
    		 -5.11M -7.47M -6.39M -6.67M 252.46K 489.83K -4.58M -5.04M 616.3K 611.73K 380.81K -7.42M -2.3M -9.39K
    Net Income
    		 -5.37M -7.74M -6.66M -6.81M -4.77M -4.84M -4.73M -5.19K 616.3K 611.73K 380.81K -8.57K -2.3M -9.39K
    Selling & General & Admin
    		 4.01M 4.33M 5.13M 5.37M 3.5M 3.34M 3.43M 3.89M 1.35M 1.87M 774.15K 2.17M 685.5K n/a
    Research & Development
    		 938.28K 3.14M 1.26M 1.3M 1.13M 1.35M 1.15M 1.15M 1.24M 919.31K 934.28K 5.24M 1.61M n/a
    Other Expenses
    		 n/a n/a n/a n/a n/a n/a n/a -4.62M -2.38M -2.64M -1.57M n/a n/a n/a
    Operating Expenses
    		 4.94M 7.47M 6.39M 6.67M 4.63M 4.69M 4.58M 421.45K 199.55K 147.92K 138.12K 7.42M 2.3M n/a
    Interest Expense
    		 160.75K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 4.94M 7.47M 6.39M 6.67M 4.63M 4.69M 4.58M 421.45K 199.55K 147.92K 138.12K 7.42M 2.3M n/a
    Income Tax Expense
    		 264.24K 264.24K 264.24K 144K 144K 144K 144K 144K 2.73K 2.93K 1.85K 8.57K 2.3K n/a
    Shares Outstanding (Basic)
    		 71.55M 71.55M 71.55M 71.55M 66.53M 66.53M 89.41M 89.42M 90.16M 90.16M 90.16M 90.16M 81.4M 66.42M
    Shares Outstanding (Diluted)
    		 71.55M 71.55M 71.55M 71.55M 66.53M 66.53M 89.41M 89.42M 90.16M 90.16M 90.16M 90.16M 81.4M 66.42M
    EPS (Basic)
    		 -0.07 -0.11 -0.09 -0.1 -0.07 -0.07 -0.06 0.02 0.07 0.07 0.04 -0.00 -0.03 -0.00
    EPS (Diluted)
    		 -0.07 -0.11 -0.09 -0.1 -0.07 -0.07 -0.06 0.02 0.07 0.07 0.04 -0.00 -0.03 -0.00
    EBITDA
    		 -4.94M -7.47M -6.39M -6.67M 252.46K 489.83K 1.03M 157.94K 616.3K 611.73K 380.81K n/a n/a -9.39K
    EBIT
    		 -4.94M -7.47M -6.39M -6.67M 252.46K 489.83K 1.03M 157.94K 616.3K 611.73K 380.81K -7.42M -2.3M -9.39K
    Depreciation & Amortization
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

    Add to Watchlist